Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy

Xu Lei; Yu Lei; Jin-Ke Li; Wei-Xing Du; Ru-Gui Li; Jing Yang; Jian Li; Fang Li; Hua-Bing Tan

doi:10.1016/j.canlet.2019.11.009

journal article Feb 01, 2020

Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy

Xu Lei Yu Lei

Jin-Ke Li Wei-Xing Du Ru-Gui Li Jing Yang

Jian Li

Fang Li

Hua-Bing Tan

Cancer Letters Vol. 470 pp. 126-133 · Elsevier BV

View at Publisher Save 10.1016/j.canlet.2019.11.009

Topics

No keywords indexed for this article. Browse by subject →

References

111

[1]

The Hallmarks of Cancer

Douglas Hanahan, Robert A Weinberg

Cell 2000 10.1016/s0092-8674(00)81683-9

[2]

Hallmarks of Cancer: The Next Generation

Douglas Hanahan, Robert A. Weinberg

Cell 2011 10.1016/j.cell.2011.02.013

[3]

Yost "Clonal replacement of tumor-specific T cells following PD-1 blockade" Nat. Med. (2019) 10.1038/s41591-019-0522-3

[4]

Single-cell RNA sequencing to explore immune cell heterogeneity

Efthymia Papalexi, Rahul Satija

Nature Reviews Immunology 2017 10.1038/nri.2017.76

[5]

Zheng "Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing" Cell (2017) 10.1016/j.cell.2017.05.035

[6]

Spitzer "Mass cytometry: single cells, many features" Cell (2016) 10.1016/j.cell.2016.04.019

[7]

Wang "Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3" Cell (2019) 10.1016/j.cell.2018.11.010

[8]

Tanaka "Successful adoptive immunotherapy of murine poorly immunogenic tumor with specific effector cells generated from gene-modified tumor-primed lymph node cells" J. Immunol. (1999) 10.4049/jimmunol.162.6.3574

[9]

Farhood "CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review" J. Cell. Physiol. (2019) 10.1002/jcp.27782

[10]

Mikucki "Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints" Nat. Commun. (2015) 10.1038/ncomms8458

[11]

Spranger "Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy" Cancer Cell (2017) 10.1016/j.ccell.2017.04.003

[12]

Bennett "Induction of a CD8(+) cytotoxic T lymphocyte response by cross-priming requires cognate CD4(+) T cell help" J. Exp. Med. (1997) 10.1084/jem.186.1.65

[13]

Bennett "Help for cytotoxic-T-cell responses is mediated by CD40 signalling" Nature (1998) 10.1038/30996

[14]

T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions

Stephen P. Schoenberger, René E. M. Toes, Ellen I. H. van der Voort et al.

Nature 1998 10.1038/31002

[15]

Bourgeois "A role for CD40 expression on CD8(+) T cells in the generation of CD8(+) T cell memory" Science (2002) 10.1126/science.1072615

[16]

Mackey "The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells" J. Leukoc. Biol. (1998) 10.1002/jlb.63.4.418

[17]

Mackey "Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154" Cancer Res. (1997)

[18]

Cheng "Enhanced signaling through the IL-2 receptor in CD8(+) T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8(+) T cells rather than promotion of cell death" Proc. Natl. Acad. Sci. U. S. A (2002) 10.1073/pnas.052676899

[19]

Ahrends "The opposing roles of CD4(+) T cells in anti-tumour immunity" Immunology (2018) 10.1111/imm.12941

[20]

CD4+ T cell help in cancer immunology and immunotherapy

Jannie Borst, Tomasz Ahrends, Nikolina Bąbała et al.

Nature Reviews Immunology 2018 10.1038/s41577-018-0044-0

[21]

Watts "T cell co-stimulatory molecules other than CD28" Curr. Opin. Immunol. (1999) 10.1016/s0952-7915(99)80046-6

[22]

Enhancement of Antitumor Immunity by CTLA-4 Blockade

Dana R. Leach, Matthew F. Krummel, James P. Allison

Science 1996 10.1126/science.271.5256.1734

[23]

Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Gordon J. Freeman, Andrew J. Long, Yoshiko Iwai et al.

Journal of Experimental Medicine 2000 10.1084/jem.192.7.1027

[24]

Sanchez-Fueyo "Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance" Nat. Immunol. (2003) 10.1038/ni987

[25]

Das "Tim-3 and its role in regulating anti-tumor immunity" Immunol. Rev. (2017) 10.1111/imr.12520

[26]

Lichtenegger "Targeting LAG-3 and PD-1 to enhance T cell activation by antigen-presenting cells" Front. Immunol. (2018) 10.3389/fimmu.2018.00385

[27]

Joller "Tim-3, Lag-3, and TIGIT" Curr. Top. Microbiol. (2017)

[28]

Dougall "TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy" Immunol. Rev. (2017) 10.1111/imr.12518

[29]

Dong "ICOS co-stimulatory receptor is essential for T-cell activation and function" Nature (2001) 10.1038/35051100

[30]

Yoshinaga "T-cell co-stimulation through B7RP-1 and ICOS" Nature (1999) 10.1038/45582

[31]

Kaleeba "The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells" Int. Immunol. (1998) 10.1093/intimm/10.4.453

[32]

Vinay "Role of 4-1BB in immune responses" Semin. Immunol. (1998) 10.1006/smim.1998.0157

[33]

Kwon "New insights into the role of 4-1BB in immune responses: beyond CD8(+) T cells" Trends Immunol. (2002) 10.1016/s1471-4906(02)02263-9

[34]

Knee "Rationale for anti-GITR cancer immunotherapy" Eur. J. Cancer (2016) 10.1016/j.ejca.2016.06.028

[35]

van de Ven "Targeting the T-cell co-stimulatory CD27/CD70 pathway in cancer immunotherapy: rationale and potential" Immunotherapy (2015) 10.2217/imt.15.32

[36]

Ware "Targeting the LIGHT-HVEM pathway, Therapeutic targets of the Tnf superfamily" (2009)

[37]

Hollenbaugh "The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity" EMBO J. (1992) 10.1002/j.1460-2075.1992.tb05530.x

[38]

Iwai "Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade" Proc. Natl. Acad. Sci. U. S. A (2002) 10.1073/pnas.192461099

[39]

Pauken "SnapShot: T cell exhaustion" Cell (2015) 10.1016/j.cell.2015.10.054

[40]

Guillerey "Targeting natural killer cells in cancer immunotherapy" Nat. Immunol. (2016) 10.1038/ni.3518

[41]

Habif "Targeting natural killer cells in solid tumors" Cell. Mol. Immunol. (2019) 10.1038/s41423-019-0224-2

[42]

Voskoboinik "Perforin-mediated target-cell death and immune homeostasis" Nat. Rev. Immunol. (2006) 10.1038/nri1983

[43]

Krneta "The breast tumor microenvironment alters the phenotype and function of natural killer cells" Cell. Mol. Immunol. (2016) 10.1038/cmi.2015.42

[44]

Zhang "Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity" Nat. Immunol. (2018) 10.1038/s41590-018-0132-0

[45]

Batista "The who, how and where of antigen presentation to B cells" Nat. Rev. Immunol. (2009) 10.1038/nri2454

[46]

Michielsen "Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer" PLoS One (2011) 10.1371/journal.pone.0027944

[47]

Krempski "Tumor-infiltrating programmed death receptor-1(+) dendritic cells mediate immune suppression in ovarian cancer" J. Immunol. (2011) 10.4049/jimmunol.1100274

[48]

Aras "TAMeless traitors: macrophages in cancer progression and metastasis" Br. J. Canc. (2017) 10.1038/bjc.2017.356

[49]

Narayanan "Tumor infiltrating lymphocytes and macrophages improve survival in microsatellite unstable colorectal cancer" Ann. Surg. Oncol. (2018)

[50]

Mantovani "Tumour-associated macrophages as treatment targets in oncology" Nat. Rev. Clin. Oncol. (2017) 10.1038/nrclinonc.2016.217

Showing 50 of 111 references

Cited By

1,263

Mitochondrial ribosomal protein S24 is associated with immunosuppressive microenvironment and cold tumor in lung adenocarcinoma

Yanni Gao, Yilin Yu · 2024

Heliyon

Regulation of T cells in the tumor microenvironment by histone methylation: LSD1 inhibition—a new direction for enhancing immunotherapy

Xie Xueqing, Peng Yongcan · 2024

Heliyon

Identifying the signature of NAD+ metabolism-related genes for immunotherapy of gastric cancer

Huijuan Wen, Yang Mi · 2024

Heliyon

Spatial transcriptomics reveals the interplay between cancer and immune cells directed by MXene quantum dots

Ahmet Ceylan, Recep Uyar · 2024

Nano Today

Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer

Yang Zhang, Qianming Kang · 2024

Chinese Medicine

E3 ubiquitin ligase HECW2: a promising target for tumour therapy

Hui Shen, Qianrui Kou · 2024

Cancer Cell International

Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression

Cuncan Deng, Mingyu Huo · 2024

Molecular Cancer

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications

Jianwen Fang, Yue Lu · 2023

Cell Death & Disease

Bispecific antibodies in cancer therapy: Target selection and regulatory requirements

Yanze Sun, Xinmiao Yu · 2023

Acta Pharmaceutica Sinica B

Pan‐cancer analysis: SPAG5 is an immunological and prognostic biomarker for multiple cancers

Xiaofeng Gao, Huitong Bu · 2023

The FASEB Journal

Expression characteristic, immune signature, and prognosis value of EFNA family identified by multi-omics integrative analysis in pan-cancer

Zonglin Jiao, Xiao Feng · 2022

BMC Cancer

Metrics

1,263

Citations

111

References

Details

Published: Feb 01, 2020
Vol/Issue: 470
Pages: 126-133
License: View

Authors

Institute of Image Processing and Pattern Recognition, Shanghai Jiao Tong University, and Key Laboratory of System Control and Information Processing, Ministry of Education of China, Shanghai 200240, China

Ji Hua Laboratory

University of Minnesota

H

Hua-Bing Tan

Cite This Article

Xu Lei, Yu Lei, Jin-Ke Li, et al. (2020). Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Letters, 470, 126-133. https://doi.org/10.1016/j.canlet.2019.11.009

Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy

You May Also Like